{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:07:22Z","timestamp":1759334842125,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.jaad.2009.04.037","type":"journal-article","created":{"date-parts":[[2010,6,12]],"date-time":"2010-06-12T04:41:30Z","timestamp":1276317690000},"page":"e5-e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Varenicline-induced drug eruption with resulting palmar\/plantar hyperhidrosis and dysesthesia"],"prefix":"10.1016","volume":"63","author":[{"given":"Matilda W.","family":"Nicholas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arin","family":"Isenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Dasher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Granko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Lugo-Somolinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Groben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean S.","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.04.037_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2009.04.037_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2009.04.037_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.296.1.64","article-title":"Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial","volume":"296","author":"Tonstad","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2009.04.037_bib4","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.2146\/ajhp070641","article-title":"Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression","volume":"65","author":"Pirmoradi","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jaad.2009.04.037_bib5","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jama.299.10.1121","article-title":"FDA warns of adverse events linked to smoking cessation drug and antiepileptics","volume":"299","author":"Kuehn","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2009.04.037_bib6","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2146\/ajhp070458","article-title":"Diffuse exanthema in a patient receiving varenicline","volume":"65","author":"Song","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jaad.2009.04.037_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/mol.106.025130","article-title":"Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors","volume":"70","author":"Mihalak","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaad.2009.04.037_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.0022-202X.2004.23425.x","article-title":"Phenotypical and molecular profiling of the extraneuronal cholinergic system of the skin","volume":"123","author":"Kurzen","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2009.04.037_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaad.2009.04.037_bib10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1345\/aph.17382","article-title":"Nicotine replacement therapy","volume":"32","author":"Thompson","year":"1998","journal-title":"Ann Pharmacother"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209005246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209005246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:17:40Z","timestamp":1759270660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209005246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0190962209005246"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.04.037","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varenicline-induced drug eruption with resulting palmar\/plantar hyperhidrosis and dysesthesia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}